Global Granisetron Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Granisetron Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
Granisetron report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Granisetron market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chemotherapy and Post operative are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Granisetron industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Granisetron key companies include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, Teva, Cipla, Sandoz, Wockhardt and Mylan, etc. Kyowa Kirin, Heron Therapeutics, Fresenius Kabi are top 3 players and held % share in total in 2022.
Granisetron can be divided into Transdermal system, Injection and Oral,, etc. Transdermal system is the mainstream product in the market, accounting for % share globally in 2022.
Granisetron is widely used in various fields, such as Chemotherapy and Post operative, etc. Chemotherapy provides greatest supports to the Granisetron industry development. In 2022, global % share of Granisetron went into Chemotherapy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Granisetron market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
Segment by Type
Transdermal system
Injection
Oral
Chemotherapy
Post operative
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Granisetron market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Granisetron introduction, etc. Granisetron Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Granisetron market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Granisetron report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Granisetron market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Chemotherapy and Post operative are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Granisetron industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Granisetron key companies include Kyowa Kirin, Heron Therapeutics, Fresenius Kabi, Hikma Pharmaceuticals, Teva, Cipla, Sandoz, Wockhardt and Mylan, etc. Kyowa Kirin, Heron Therapeutics, Fresenius Kabi are top 3 players and held % share in total in 2022.
Granisetron can be divided into Transdermal system, Injection and Oral,, etc. Transdermal system is the mainstream product in the market, accounting for % share globally in 2022.
Granisetron is widely used in various fields, such as Chemotherapy and Post operative, etc. Chemotherapy provides greatest supports to the Granisetron industry development. In 2022, global % share of Granisetron went into Chemotherapy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Granisetron market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
Segment by Type
Transdermal system
Injection
Oral
Segment by Application
Chemotherapy
Post operative
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Granisetron market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Granisetron introduction, etc. Granisetron Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Granisetron market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices